NLRP6 and NLRP12 have been found to attenuate NF-kB and MAPK in models of colitis and CRC [14–17], NLRC3 has been shown to act as a negative regulator of TLR and DNA-induced cytokine production [9, 10]. This evidence concerns the gene NFKB1 and colorectal carcinoma.